Denver, CO— SmartTab will join a select group of Colorado startups to exhibit at the world’s largest trade fair for medical technology. The MEDICA HEALTH IT FORUM takes place in Düsseldorf, Germany on November 18-21.
The Colorado Office of Economic Development and International Trade (OEDIT) selected SmartTab to attend MEDICA as an emerging health tech company. OEDIT provides financial assistance for companies entering new global markets through the State Trade Expansion Program (STEP). Staff from SmartTab will host a booth in the Colorado Pavilion as well as meet with potential partners and investors. In the future, SmartTab may expand into Europe as leaders pursue exporting and manufacturing opportunities.
"Colorado is pioneering leading edge technologies in healthcare and delivering a range of high-tech digital products. It is great to be part of this local Denver startup community and now taking SmartTab to the next level in Europe."
Robert Niichel, SmartTab™ Founder and CEO
MEDICA provides expert panels and speakers on developments in the field of digital health solutions. The event attracts roughly 120,00 visitors to meet with 5,100 exhibitors. The trade show provides opportunities to meet potential buyers, test market interest and evaluate the competition. SmartTab will join the extensive exhibition of innovations for outpatient and clinical care.
Velóce Corporation is developing the SmartTab Drug Delivery and Monitoring System, a revolutionary way to deliver medicine. The ingestible capsule is wirelessly powered and remote controlled by an electronic receiver/monitor and smart polymer actuator.
SmartTab can deliver active ingredients to highly specific areas in the human body at specific times or in response to a monitored physiological condition. The system will interface with wearable technology to interact with Learning Artificial Intelligence Healthcare Systems. The SmartTab capsule can deliver a wide range of active ingredients and interact with the Internet of Medical Things (IoMT) to optimize patient outcomes, significantly increase prescription drug adherence, and drastically reduce healthcare costs.
